Skip to main content
Ensol Biosciences Inc. logo

Ensol Biosciences Inc. — Investor Relations & Filings

Ticker · 140610 ISIN · KR7140610007 KO Manufacturing
Open in API
Filings indexed 257 across all filing types
Latest filing 2025-06-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 140610

About Ensol Biosciences Inc.

https://www.ensolbio.co.kr/eng/

Ensol Biosciences Inc. is a biopharmaceutical company focused on developing innovative drugs for diseases with limited or no therapeutic alternatives. The company leverages a bio big data and AI-driven platform for its research and development activities. A core area of its technology involves Protein-Protein Interaction (PPI)-regulating short peptide drugs, which are designed for local injection to maximize therapeutic effects and minimize systemic side effects through high specificity and a short half-life in the blood. The company's pipeline targets a range of medical unmet needs, including degenerative disc disease, osteoarthritis, cancer, and neurodegenerative disorders like Alzheimer's disease. Key clinical-stage assets include E1K for osteoarthritis (preparing for Phase 3) and C1K, an anticancer combination therapy (Phase 1).

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is an official regulatory filing regarding a change in the company's largest shareholder (maximum shareholder). It details the transition from the previous major shareholder to a new one due to a stock purchase agreement. This type of disclosure is a standard regulatory requirement for public companies to report changes in control or significant ownership structures. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for institutional investors crossing thresholds), and it is a formal regulatory announcement of a corporate event, it is best classified as a Regulatory Filing (RNS).
2025-06-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the disposal of shares by Yuhan Corporation in Ensol Biosciences. This type of filing is specifically used to notify the market when a major shareholder crosses a reporting threshold or changes their stake significantly. In the provided taxonomy, this falls under 'Major Shareholding Notification'.
2025-06-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the acquisition of shares by a major shareholder (Hyung Inwoo) in Ensol Biosciences, including the number of shares, percentage of ownership, and the purpose of the holding (simple investment). This falls under the category of Major Shareholding Notification.
2025-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a change in shareholding by a major shareholder (Hyung Inwoo) in Ensol Biosciences. This is a standard regulatory filing for insider/major shareholder transactions, which falls under the 'Director's Dealing' category (DIRS) in the provided schema, as it reports personal share transactions by a major shareholder/director.
2025-06-11 Korean
최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is an official regulatory announcement regarding a change in the company's largest shareholder due to a stock purchase agreement (share transfer). It details the parties involved, the number of shares, the transaction price, and the resulting change in ownership percentage. This falls under the category of major shareholding notifications or changes in control, which is best classified as MRQ (Major Shareholding Notification) as it specifically addresses the change in the largest shareholder status.
2025-06-11 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by Ensol Biosciences. It details the date, location, participants, and agenda of the meeting. Since it is a regulatory announcement confirming the occurrence and outcome of an IR event rather than the presentation slides themselves, it falls under the category of general regulatory filings or announcements.
2025-05-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.